Fig. 1

a-c Meta-analysis glycemic control standardized mean differences estimates for (a) high-sensitivity C-reactive protein, (b) for interlokin-6, and (c) for tumor necrosis factor alpha in alpha-lipoic acid supplements and placebo groups (CI = 95%)